U
HITK

UBS’s HI-TECH PHARMACAL INC HITK Stock Holding History

UBS’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200
Closed -$9K – 11339
2013
Q4 		$9K Hold
200
– – ﹤0.01% 9158
2013
Q3 		$9K Buy
200
+100
+100% +$3.83K ﹤0.01% 8976
2013
Q2 		$3K Buy
+100
New +$3.33K ﹤0.01% 9721

UBS's HITK Position: Q2 2014 in Review

UBS sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 500 shares — an estimated $22K sold.

UBS first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $203K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • UBS reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • UBS sold 500 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $22K.
  • UBS first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • UBS's HI-TECH PHARMACAL INC position peaked at $203K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.